Cytokine expression and AIF-1-mediated activation of Rac2 in vascular smooth muscle cells: a role for Rac2 in VSMC activation.
Allograft inflammatory factor-1 (AIF-1) is a cytoplasmic, calcium-binding, inflammation-responsive scaffold protein involved in vascular smooth muscle cell (VSMC) migration and proliferation. The objective of this study is to characterize AIF-1 functional protein interactions that may regulate VSMC activation. Through use of a bacterial two-hybrid screen, we identified a molecular interaction between AIF-1 and the small GTPase, Rac2, which was verified by pull-down and colocalization experiments. This was unexpected in that Rac2 expression had been considered to be restricted to hematopoietic cells. The Rac2/AIF-1 interaction is functional, in that a loss-of-function, point-mutated AIF-1 does not interact with Rac2; Rac2 colocalizes with AIF-1 in the cytoplasm of VSMC and cotranslocates to lamellopodia upon platelet-derived growth factor stimulation; and AIF-1 expression in VSMC leads to Rac2 activation. Because Rac2 function in VSMC had not been described, we focused on characterization of its function in these cells. Rac2 protein expression in VSMC is inducible by inflammatory cytokines, and Rac2 activation in VSMC is also responsive to inflammatory cytokines. Rac2 expression and activation patterns differ from the ubiquitously expressed Rac1. We hypothesized that Rac2 participates in VSMC activation. Retroviral overexpression of Rac2 in primary VSMC leads to increased migration, activation of the NADPH oxidation cascade, and increased activation of the Rac2 effector protein Pak1 and its proximal effectors, ERK1/2, and p38 (P < 0.05 for all). The major points of this study indicate a functional interaction between AIF-1 and Rac2 in VSMC leading to Rac2 activation and a potential function for Rac2 in inflammation-driven VSMC response to injury.
Tian
Ying
Y
Dept. of Physiology, Cardiovascular Research Center, Temple Univ. School of Medicine, Philadelphia, PA 10140, USA.
Autieri
Michael V
MV
D000818:Animals; D001011:Aorta / Q000166:cytology; D002135:Calcium-Binding Proteins / Q000502:physiology*; D002465:Cell Movement; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis*; D020935:MAP Kinase Signaling System / Q000502:physiology; D008840:Microfilament Proteins; D032389:Myocytes, Smooth Muscle / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D017354:Point Mutation; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D020744:rac GTP-Binding Proteins / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D020830:rac1 GTP-Binding Protein / Q000502:physiology; D000097766:RAC2 GTP-Binding Protein
D002135:Calcium-Binding Proteins; D016207:Cytokines; D008840:Microfilament Proteins; D009249:NADP; D020744:rac GTP-Binding Proteins; D020830:rac1 GTP-Binding Protein; D000097766:RAC2 GTP-Binding Protein; C100745:Aif1 protein, rat; C499134:Rac1 protein, rat